Upcoming Virtual Discussion on Reducing High Prescription Drug Prices Without Impacting Innovation
Patients for Affordable Drugs will host a virtual session on overcoming high drug prices on May 18th at 7 PM [...]
New Report Offers Global Market Insight and Highlights Critical HEOR RWD Trends
A new report discusses health economics and outcomes research (HEOR) trends expected to impact the global economy for the next [...]
New Study Analyzes List and Net Prices of Diabetes Drugs
A new study considers the prices of three categories of drugs used in diabetes. The authors note an increase in [...]
New Report Discusses RWD and RWE in Regulatory Approval Process, Notes 82% of Submissions Using RWE Gain Orphan Drug Designation
A report published in Clinical Pharmacology & Therapeutics discusses the use of RWD (real world data) and RWE (real world [...]
New Whitepaper Features Insight on Virtual Stakeholder Engagement
A new whitepaper discusses how life sciences companies can optimize their stakeholder engagement strategies. Although virtual engagement was taking place [...]
Can Companies Order COVID-19 Vaccination? Legal Challenges Have Begun
The US is rapidly vaccinating its population with vaccines that received the Emergency Use Authorization (EUA) by the Food and [...]
COVID-19 Leaves Companies Wondering How to Navigate the Future
The impact of COVID-19 cannot be understated. Kantar’s Chief Procurement Officer (CPO) Stephen Day discusses his thoughts on industry trends [...]
HealthVerity Clinical Trial Optimization Approach Considers RWD Advantages and Promotes Equity
RWD (real world data) is changing the way clinical trials are designed and conducted. HealthVerity discusses important consideration for using [...]
ICER Whitepaper on Successfully Navigating the FDA’s Accelerated Approval Pathway
Today, ICER (the Institute for Clinical and Economic Review) announced a new whitepaper on understanding and navigating the FDA’s accelerated [...]
Seqster Develops Streamlined Patient Healthcare Platform, Raises $12 Million in Funding
Data aggregator Seqster has raised $12 million in startup funding. The company offers a single platform for EHR (electronic health [...]
New Study Highlights Impact of Women Leaders Throughout Companies
As women have been promoted to top-level positions, positive consequences including more profitable companies and better customer experiences have been [...]
Will Biden Budget Tackle Drug Pricing?
The Biden administration has announced its skinny budget. One major omission was any mention of drug pricing regulation. However, the [...]
West Virginia Takes Legislative Action to Lower Drug Costs, Improve Health Equity
West Virginia passed a law that will compel payers and PBMs (Pharmacy Benefit Managers) to pass on medication savings to [...]
HealthVerity Offers Webinar on HEOR and RWD
HealthVerity will offer a webinar on Wednesday, May 5th at 1:00 PM EDT. Speakers will discuss how to effectively use [...]
New Report on Utilizing RWE in Drug Development Pipeline Throughout the Globe
A new report by consulting group Roots Analysis has been published. It features insight on RWE (real world evidence) when [...]
Maine Citizens Demand Prescription Drug Pricing Action in Public Hearing; 219,000 Mainers Can’t Afford Medication
Maine recently held a public meeting where Mainers discussed how skyrocketing drug prices lead to extreme financial hardship, pain, and [...]
AMCP Partnership Forum Discusses State of Rare Disease Outcomes and Research, Orphan Drugs to Hit $242 Billion by 2024
The AMCP (Academy of Managed Care Pharmacy) held a virtual meeting for healthcare professionals, payers, researchers, and pharma companies in [...]
How Will States Tackle Unsupported Price Increases?
ICER’s report on UPIs (Unsupported Price Increases) has led lawmakers to consider legislative measures to restrict the prices of prescription [...]
New Book on Pharma Market Access Now Available
A new book by Kasem Akhras, PharmD, is now available on Amazon, both as a physical book and as an [...]
Scientist.com Named Among Top 500 Fastest-Growing Companies in The Americas, Number 12 in Health Category According to The Financial Times
Scientist.com, the parent company of HealthEconomics.Com, has been recognized as number 132 of the top 500 Fastest Growing Companies in [...]
Are They Really Orphans? New Report Highlights Misuse of Orphan Drug Designation Driving High Prices
A study recently published in Health Affairs examines whether or not orphan drugs fit the criteria allowing them special privileges [...]
PhRMA Kicks Off New Agenda, Including Endorsement of Drug Pricing Reforms
National lobbying group PhRMA introduced a new agenda this week with a pointed message at the White House: pharma has [...]
ICER Publishes Methodology on Evaluating Unsupported Drug Price Increases
ICER has released a protocol detailing how it analyses UPIs (Unsupported Price Increases) for prescription drugs in the United States. [...]
Understanding the Expanded Role of the Medical Affairs Professional
Medical affairs professionals are responsible for representing their organizations and clearly conveying important information. In some cases, they can also [...]
The Patient Side of Successful Drug Development
More and more, patient opinions are being considered when it comes to designing effective therapeutics and testing their efficacy. A [...]